an OPEN Health Company

Section Links

Newsletter Signup

New poster presentation: Levodopa/Carbidopa treatment

You are currently in: Home > Latest News > New poster presentation: Levodopa/Carbidopa treatment

Date: 4/9/2014

A real world study characterising the UK population treated with a real-world study to characterise the UK population treated with levodopa/carbidopa intestinal gel (LCIG) was presented today at the World Congress on NeuroTherapeutics: Dilemmas, Debates & Discussions (DDDN) .
Authors: K. Ray Authors: Chaudhuri, Mark Kellett, Patricia Limousin, David Burn, Jaydeep Sinha

pH Associates developed the protocol in conjunction with the sponsor, Abbvie and the clinical experts, obtained ethical approval and set up the 15 centres who were involved. Data was collected by the NHS centres with pH being responsible for the data entry, cleaning, analysis and reporting.

>> To Top    >> Back